Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

v3.23.3
NET LOSS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2023
NET LOSS PER SHARE  
Schedule of dilutive securities have been excluded from the computation of diluted net loss per share

Nine Months Ended

September 30, 

    

2023

    

2022

Warrants

 

27,148,243

(1)

1,563,381

Preferred shares as convertible into common stock

 

111,111

 

111,111

Stock options

 

2,280,756

 

654,263

Total potentially dilutive shares

 

29,540,110

 

2,328,755

(1) As of September 30, 2023 the Convertible Preferred Series E-1 Shares were not convertible, pending stockholder approval of the transaction and are therefore excluded from this table.